FY13 Pre-Sequestration Budget Update

Last February, the Obama administration requested $30.6B for the NIH, the same as in FY12. In June, the Senate appropriations committee bumped this up by $100M to $30.7B.

Yesterday, the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies approved an HHS appropriations bill (pp 50-58) that uses the $30.6B funding level and worse, as Tony Mazzaschi at AAMC describes it, “micromanages” how HHS agencies can spend the money: no “economic research” at the NIH, no “patient-oriented outcomes research” by any HHS agency (in other words, no research that might benefit health care reform). AHRQ would be terminated, in fact.

At least Collins gets to keep his job … though he does lose his discretionary fund, and he is charged to “ensure that at least 16,670 new and competing Ruth L. Kirschstein National Research Service Awards are funded in fiscal year 2013.” Good news for F and T32 trainees (who knows where they find get jobs) … bad news for ICs who may therefore need to shift the burden of sequestration to RPGs or other mechanisms.

The micromanaging doesn’t stop there. The section on the NCATS appropriation ($64M less than the Administration requested) reads:

For carrying out section 301 and title IV of the PHS Act with respect to translational sciences, $574,713,000: Provided, That up to $10,000,000 shall be available to implement section 402C of the PHS Act (relating to the Cures Acceleration Network) after NIH has published in the Federal Register a notice of proposed rulemaking and request for comments with respect to a rule to ensure that all programs, projects, and activities of the National Center for Advancing Translational Sciences do not create duplication, redundancy or competition with industry: Provided further, That at least $487,767,000 is provided to the Clinical and Translational Sciences Awards (CTSA) program: Provided further, That no changes shall be made to the CTSA program until the date on which the Institute of Medicine (referred to in this title as ‘‘IOM’’) review described in the joint explanatory statement accompanying Public Law 112–74 is completed.

Out of the $2.5B set aside for NIGMS, $376.5M must go toward the IDeA program. At NIEHS, the string attached to their $684,755,000 is “that none of the funds … may be used by the National Toxicology Program (NTP) for purposes of the Report on Carcinogens (ROC) unless and until 30 days after the National Academy of Sciences (NAS) peer review of the ROC process and listing criteria requested in the joint explanatory statement accompanying Public Law 112–74 has been completed.”

And the sausage making has just begun.


  1. friend said

    Is it really that bad?

    • writedit said

      If Congress can come up with a deficit-reducing alternative to sequestration, then paylines will only go down slightly (plus no increase for inflation, all awarded budgets cut). If the NIH is hit with an 8% reduction on top of no increase, paylines will definitely suffer.

  2. […] Work-Life Balance: You keep using those words… (excellent) ‘First’ 50-eyed flatworm discovered in Cambridgeshire Anti-vaccination propagandists help create the worst whooping cough epidemic in 70 years Galápagos Monday: The People Problem FY13 Pre-Sequestration Budget Update […]

  3. […] so they can support their personnel and research. Considering plans for the next fiscal year, the budget will be essentially flat – at best. That’s provided Congress can come to an agreement on deficit reduction in the […]

RSS feed for comments on this post · TrackBack URI

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: